Clinical Trial Update: Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC [Phase 2]

View source ↗

Summary

Phase II randomized trial at Fox Chase Cancer Center evaluating adding atezolizumab to carboplatin, pemetrexed, and bevaciuzmab vs. standard chemo-immunotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Phase 2 | Status: RECRUITING